222 related articles for article (PubMed ID: 32413029)
1. SULF1 suppresses Wnt3A-driven growth of bone metastatic prostate cancer in perlecan-modified 3D cancer-stroma-macrophage triculture models.
Brasil da Costa FH; Lewis MS; Truong A; Carson DD; Farach-Carson MC
PLoS One; 2020; 15(5):e0230354. PubMed ID: 32413029
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
[TBL] [Abstract][Full Text] [Related]
3. Matrilysin/MMP-7 Cleavage of Perlecan/HSPG2 Complexed with Semaphorin 3A Supports FAK-Mediated Stromal Invasion by Prostate Cancer Cells.
Grindel BJ; Martinez JR; Tellman TV; Harrington DA; Zafar H; Nakhleh L; Chung LW; Farach-Carson MC
Sci Rep; 2018 May; 8(1):7262. PubMed ID: 29740048
[TBL] [Abstract][Full Text] [Related]
4. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
Cruz LA; Tellman TV; Farach-Carson MC
Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
[TBL] [Abstract][Full Text] [Related]
5. Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients.
Grindel B; Li Q; Arnold R; Petros J; Zayzafoon M; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Oncotarget; 2016 Mar; 7(9):10433-47. PubMed ID: 26862737
[TBL] [Abstract][Full Text] [Related]
6. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
[TBL] [Abstract][Full Text] [Related]
7. Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.
Hubka KM; Carson DD; Harrington DA; Farach-Carson MC
Acta Biomater; 2019 Oct; 97():385-398. PubMed ID: 31351252
[TBL] [Abstract][Full Text] [Related]
8. SULFs in human neoplasia: implication as progression and prognosis factors.
Bret C; Moreaux J; Schved JF; Hose D; Klein B
J Transl Med; 2011 May; 9():72. PubMed ID: 21599997
[TBL] [Abstract][Full Text] [Related]
9. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Grindel BJ; Martinez JR; Pennington CL; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Matrix Biol; 2014 Jun; 36():64-76. PubMed ID: 24833109
[TBL] [Abstract][Full Text] [Related]
10. Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.
Kalus I; Rohn S; Puvirajesinghe TM; Guimond SE; Eyckerman-Kölln PJ; Ten Dam G; van Kuppevelt TH; Turnbull JE; Dierks T
PLoS One; 2015; 10(10):e0139853. PubMed ID: 26448642
[TBL] [Abstract][Full Text] [Related]
11. Tumour-associated macrophages are recruited and differentiated in the neoplastic stroma of oral squamous cell carcinoma.
Essa AA; Yamazaki M; Maruyama S; Abé T; Babkair H; Raghib AM; Megahed EM; Cheng J; Saku T
Pathology; 2016 Apr; 48(3):219-27. PubMed ID: 27020496
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
[TBL] [Abstract][Full Text] [Related]
13. The role of tumor microenvironment in prostate cancer bone metastasis.
Morrissey C; Vessella RL
J Cell Biochem; 2007 Jul; 101(4):873-86. PubMed ID: 17387734
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1.
Barcellos-de-Souza P; Comito G; Pons-Segura C; Taddei ML; Gori V; Becherucci V; Bambi F; Margheri F; Laurenzana A; Del Rosso M; Chiarugi P
Stem Cells; 2016 Oct; 34(10):2536-2547. PubMed ID: 27300750
[TBL] [Abstract][Full Text] [Related]
15. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
16. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
Özdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
[TBL] [Abstract][Full Text] [Related]
17. Biofunctionalization of electrospun PCL-based scaffolds with perlecan domain IV peptide to create a 3-D pharmacokinetic cancer model.
Hartman O; Zhang C; Adams EL; Farach-Carson MC; Petrelli NJ; Chase BD; Rabolt JF
Biomaterials; 2010 Jul; 31(21):5700-18. PubMed ID: 20417554
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
[TBL] [Abstract][Full Text] [Related]
19. Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins.
Ojalill M; Virtanen N; Rappu P; Siljamäki E; Taimen P; Heino J
Prostate; 2020 Jun; 80(9):715-726. PubMed ID: 32364250
[TBL] [Abstract][Full Text] [Related]
20. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.
Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA
Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]